Financhill
Back

Citius Pharmaceuticals Quote, Financials, Valuation and Earnings

Citius Pharmaceuticals Price Quote

$0.13
-0.04 (-21.26%)
(Updated: November 22, 2024 at 5:55 PM ET)

Citius Pharmaceuticals Key Stats

Sell
23
Citius Pharmaceuticals (CTXR) is a Sell

Day range:
$0.15 - $0.18
52-week range:
$0.15 - $1.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.35%

Volume:
4.6M
Avg. volume:
2.4M
1-year change:
-78.61%
Market cap:
$29.8M
Revenue:
$0
EPS:
$-0.24

How Much Does Citius Pharmaceuticals Make?

Data Unavailable

Is Citius Pharmaceuticals Growing As A Company?

Data Unavailable

Citius Pharmaceuticals Stock Price Performance

What Is Citius Pharmaceuticals 52-Week High & Low?

Citius Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Pharmaceuticals?

Is Citius Pharmaceuticals Cash Flow Positive?

  • What Is CTXR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$29.1M
  • What Is Citius Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Citius Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Citius Pharmaceuticals Return On Invested Capital

Data Unavailable

Citius Pharmaceuticals Earnings Date & Stock Price

Citius Pharmaceuticals Competitors

Citius Pharmaceuticals Dividend Yield

Citius Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.67
Upside from Last Price: 2726.57%

Major Shareholders

  • How many CTXR shares are owned by institutional investors?
    33.9M CTXR shares are owned by institutional investors
  • How many CTXR shares are owned by insiders?
    12.3M CTXR shares are owned by insiders